Skip to content

New Report from CECP’s Global Exchange Confirms Deeper and Ongoing Engagement of Multinational Companies on ESG Issues

Research project offers distinctive global view of Environmental, Social, and Governance (ESG) efforts from leading multinational corporations. Read more here...

Workplace Volunteering is Indisputable Engine of Social and Business Value Creation

When focused on community needs first, new research finds workplace volunteering can also double a customer’s loyalty to a company. Read more here...

CECP Giving in Numbers™ Survey Reveals Corporate Social Investments Up a Record 41% the Last Three Years

October 28, 2021, New York, NY— Reflecting the unprecedented experience of 2020, Chief Executives for Corporate Purpose®’s (CECP) Giving in NumbersTM report chronicles the changes in societal investment at the...

CECP Virtually Convenes CEOs of the World’s Largest Companies; Third Meeting Focuses on Public and Corporate Sector Partnerships for Recovery in 2021

January 14, 2021, New York—With the world closing out one of the most challenging years on record, yet still far from normalcy, leading corporate CEOs gathered virtually with Joe Ucuzoglu,...

CECP and Tunley Engineering Host Carbon Emission Reduction Course

October 7, 2021, New York, NY—Millions of new jobs may be created globally due to new climate policies and commitments, with the International Labor Organization (ILO) estimating that 24 million...

CEOs of Biopharmaceutical Companies Share Long-Term Business Plans with Institutional Investors

NEW YORK, June 7, 2021—Representing $800 billion in market capitalization, nine CEOs from the biopharma sector will speak virtually about their company’s long-term approach to sustainable business, June 7-8, 2021....

CECP’s CEO Investor Forum & Biopharma Sustainability Roundtable releases a joint report on Integrating Sustainability and Long-Term Planning for the Biopharma Sector

Biopharma Leaders and Institutional Investors Seeking Effective, Efficient, and Decision-Useful Communications about Long-Term Business Strategy, According to New Report from CECP’s CEO Investor Forum and the Biopharma Sustainability Roundtable. Research...

CEOs Discuss Long-Term Plans from Corporate Issuer and Investor Perspectives

March 15th, 2021, New York —Leading corporate CEOs gathered virtually with former Vanguard Chair Bill McNabb and NRG CEO Mauricio Gutierrez for Chief Executives for Corporate Purpose’s© (CECP) CEO Virtual...

CEOs of Biopharmaceutical Companies CTLT, GSK, INCY, MRK, MRNA, PFE, SNY, TAK, UCB Share Long-Term Business Plans with Investors

NEW YORK, June 7, 2021—Representing $800 billion in market capitalization, nine CEOs from the biopharma sector will speak virtually about their company’s long-term approach to sustainable business, June 7-8, 2021....

Companies Stand Firm on Their Commitments to Significant Stakeholders, Making Progress on Planet and Policies

April 5th, 2021, New York, NY— Leading companies are answering the call from their significant stakeholders to play an ever more important role in community prosperity, environmental protection, and equity,...